Publications

• Tsvetkova E, Marginean C with Nessim C and Verma S. Gastrointestinal Stromal Tumor (GIST) – Paving the Way for Modern Oncology – Epidemiology, Diagnosis, Treatment. Oncology and Hematology Review 2015, In Print
• Nessim C, Bensimon C, Hales B, Laflamme C, Fenech D, Smith A. Surgical Site Infection Prevention: A qualitative analysis on an individualized audit and feedback model. J Am Coll Surg 2012; 215(6):850- 7. doi: 10.1016/j.jamcollsurg.2012.08.007.
• Ness im C, Law C, McCo nnel l Y, Sha cha r S, McKinn on G, W ri ght F . Ho w o ften do Level III no des bea r mel a noma met asta ses an d do es it a ffe ct pa ti ent o utc ome s?  Ann Surg Oncol 2013 ; 20(6) :2056- 64. doi : 10. 1245/s 10434 - 013 - 2880- 2.
• Nessim C, Sidéris L, Turcotte S, Vafiadis P, Lapostole AC, Simard S, Koch P, Fortier LP, Dubé P. The effect of fluid overload in the presence of an epidural on the strength of colonic anastomoses. J Sur Res 2013; 183(2):567-79. doi: 10.1016/j.jss.2013.03.030.
• Nessim C, Winocour J, Holloway D., Holloway C. Wait times for Breast Cancer Surgery: Impact of the Diagnostic Pathway. J Onc Prac 2015; DOI: 10.1200/JOP.2014.002105

Publications in Progress

• Nessim C, Trop I, Robidoux A, Julian TB, Mamounas T, Boileau JF. Can MRI accurately identify which patients with operable breast cancer will have a pathologic complete response after neoadjuvant therapy? Submitting to Journal of Clinical Oncology.
• Head L, Nessim C, Arnaout A, Boyd KU. Innovative model to optimize resource utilization and improve access to care for high-risk/BRCA+ breast cancer patients.
• Crawford A, Nessim C, Weaver J, van Walraven C. Association of time to surgical management and adjuvant therapy with overall survival in Ontarians with melanoma

Book Chapters and Invited Articles

• Nessim C, Ferguson P, Gupta A, Catton C, Gladdy R. Retroperitoneal and Extremity Soft Tissue Sarcoma. Chapter in the Toronto Surgical Oncology Manual 1st edition, published in April 2012.
• Nessim C, Govidarajan A, McCart A. Peritoneal Malignancies. Chapter in the Toronto Surgical Oncology Manual 1st edition, published in April 2012.
• Nessim C, Ghazarian D. Princess Margaret Hospital: Melanoma Guidelines, PMH website, June 2012.
• Nessim C, Speakman D, Henderson M., Behan F. Management of Primary Melanoma. Melanoma Manual, book in progress to be published.

Oral Presentations

• Crawford A, Nessim C, Weaver J, van Walraven C. Association of time to surgical management and adjuvant therapy with overall survival in Ontarians with melanoma
• Canadian Association of General Surgeons, Quebec city, Quebec, Sept 17-20, 2015.
• Head L, Nessim C, Arnaout A, Boyd KU. Innovative model to optimize resource utilization and improve access to care for high-risk/BRCA+ breast cancer patients.
• Canadian Society of Plastic Surgeons Annual Meeting. Victoria, British Columbia, June 2-6, 2015.
• Nessim C, Law C, McConnell Y, Shachar S, McKinnon G, Wright F. How often do Level III nodes bear melanoma metastases and does it affect patient outcomes?
• Royal Australasian College of Surgeons 82nd Annual Scientific Congress, Auckland, New Zealand, May 6-10, 2013.
• Canadian Melanoma Conference, Banff, Alberta, February 21-24, 2013.
• Society of Surgical Oncology 65th Annual Cancer Symposium, Orlando, Florida, March 21-25, 2012.
• Canadian Society of Surgical Oncology Annual Meeting, Toronto, Ontario, April 27, 2012.
• University of Toronto Annual Assembly of General Surgeons, Toronto, Ontario, May 24, 2012.
• Nessim C, Trop I, Robidoux A, Julian TB, Mamounas T, Boileau JF. Can MRI accurately identify which patients with operable breast cancer will have a pathologic complete response after neoadjuvant therapy?
• Royal Australasian College of Surgeons 82nd Annual Scientific Congress, Auckland, New Zealand, May 6-10, 2013.
• University of Toronto Surgical Oncology Research Day. Toronto, Ontario, Feb 24, 2012.
• Nessim C, Blackstein M, Gladdy R. Desmoid Case Presentation with guest speaker Dr. Shreyaskumar Patel from MD Anderson.
• Canadian Society of Surgical Oncology Annual Meeting, Toronto, Ontario, April 29, 2011.
• Nessim C, Fourati, S., Robidoux, A., Mader, S. The Development of a PCR genetic predictive tool for the response to hormone therapy in breast cancer.
• University of Toronto Surgical Oncology Research Day. Toronto, Ontario, Feb 23, 2011.
• Montreal Biomarker Forum, Montreal, Québec, February 25, 2010.
• Nessim C, Sidéris L, Turcotte S, Vafiadis P, Lapostole AC, Simard S, Koch P, Fortier LP, Dubé P. The effect of fluid overload in the presence of an epidural on the strength of colonic anastomoses.
• 38th annual meeting of the Quebec Surgical Association. La Malbaie, Québec, June 1st, 2007.
• Scientific Symposium of the Université de Montréal Department of Surgery, Montreal, Québec, April 27-28, 2006.

Poster Presentations

• Nessim C, Trop I, Robidoux A, Julian TB, Mamounas T, Boileau JF. Can MRI accurately identify which patients with operable breast cancer will have a pathologic complete response after neoadjuvant therapy?
• ASCO Annual Meeting, Chicago Illinois, June 1-5, 2012.
• Nessim C, Winocour J, Holloway D., Holloway C. Wait times for Breast Cancer Surgery: Impact of the Diagnostic Pathway.
• American Society of Breast Surgeons 14th Annual Meeting. Phoenix, Arizona, May 1-6, 2012.
• University of Toronto Annual Assembly of General Surgeons, Toronto, Ontario, May 24, 2012.
• Nessim C, Girouard MH. Retroperitoneal Sarcoma: a case report.
• 38th annual meeting of the Quebec Surgical Association. La Malbaie, Quebec, June 1st, 2007.

Video Session Oral Presentations

• Nessim C, Garneau P. Giant Splenic Pseudocyst: Laparoscopy.
• Scientific Symposium of the Université de Montréal Department of Surgery, Montreal, Québec, April 16-17, 2007.